Our Technology

Pioneering the future of oligonucleotide therapeutics through innovative design, precise modifications, and breakthrough assay technologies

Our Technology

Pioneering the future of oligonucleotide therapeutics through innovative design, precise modifications, and breakthrough assay technologies

Molecule icon to show how ADViRNA specializes in developing precise conjugation strategies

Conjugations

We specialize in developing precise conjugation strategies that improve cellular uptake, tissue specificity, and therapeutic efficacy while maintaining the integrity of the oligonucleotide payload

Strand icon which ADViRNA studies during testing

Chemical Modifications

We employ sophisticated chemical modification strategies to optimize oligonucleotide stability, specificity, and therapeutic performance. Our deep expertise in nucleotide chemistry enables the development of highly modified oligonucleotides that resist degradation while maintaining or enhancing biological activity.

Biological sample icon which ADViRNA studies

HYBRID-ON Oligonucleotide Detection Assay

Our revolutionary HYBRID-ON oligonucleotide detection assay provides unparalleled accuracy in detecting and quantifying therapeutic oligonucleotides in complex biological samples. This breakthrough technology enables precise pharmacokinetic studies and therapeutic monitoring with exceptional sensitivity and specificity.

Ready to Advance Your Research?

Our team of experts is ready to help you design and implement the perfect solution for your specific research needs.

Ready to Advance Your Research?

Our team of experts is ready to help you design and implement the perfect solution for your specific research needs.

Our Technology